(Q34031173)

30 July 2017

title

Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti (English)

1 reference

cost-effectiveness analysis

30 July 2017

main subject

anti-retroviral agent

0 references

Haiti

1 reference

based on heuristic

inferred from title

1 reference

14

Jean W Pape

1 reference

30 July 2017

8

Daniel W Fitzgerald

1 reference

30 July 2017

3

Patrice Severe

1 reference

30 July 2017

15

Bruce R Schackman

1 reference

30 July 2017

10

Cynthia Riviere

1 reference

30 July 2017

Serena P Koenig

1

1 reference

30 July 2017

Heejung Bang

2

1 reference

30 July 2017

Marc Antoine Jean Juste

4

1 reference

30 July 2017

Alex Ambroise

5

1 reference

30 July 2017

Alison Edwards

6

1 reference

30 July 2017

Jessica Hippolyte

7

1 reference

30 July 2017

Jolion McGreevy

9

1 reference

30 July 2017

Serge Marcelin

11

1 reference

30 July 2017

Rode Secours

12

1 reference

30 July 2017

Warren D Johnson

13

1 reference

30 July 2017

language of work or name

English

0 references

publication date

20 September 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

8

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

e1001095

1 reference

Creative Commons Attribution 4.0 International

30 July 2017

copyright license

start time

20 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Early versus standard antiretroviral therapy for HIV-infected adults in Haiti

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

When to start antiretroviral therapy in resource-limited settings

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Cost analysis with censored data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Effect of early versus deferred antiretroviral therapy for HIV on survival

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

The cost of antiretroviral therapy in Haiti

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

On the equivalence of some medical cost estimators with censored data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Antiretroviral therapy in a thousand patients with AIDS in Haiti

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

On estimating medical cost and incremental cost-effectiveness ratios with censored data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Handling uncertainty in economic evaluations of healthcare interventions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3176754

Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom Collaborative ECMO Trial

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001095

Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001095

Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001095

CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21949643

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PMED.1001095

1 reference

30 July 2017

1 reference

30 July 2017

1 reference